Skip to content
10-Q

Quarterly Report

EVELO BIOSCIENCES, INC.

0001694665-23-000146

← back to feed
Filed
Aug 14, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 10, 2023 18.84M sh
Shares Diluted Q2 2023 · Jun 30, 2023 5.58M sh
Shares Diluted Q2 2023 · Jun 30, 2023 5.56M sh
Shares Diluted restated Q2 2023 · Jun 30, 2022 3.79M sh
Shares Diluted restated Q2 2023 · Jun 30, 2022 3.24M sh
Capex Q2 2023 · Jun 30, 2023 $12K
Capex Q2 2023 · Jun 30, 2022 $385K
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$40.1M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$55.46M
Long Term Debt Q2 2023 · Jun 30, 2023 $0
Long Term Debt Q2 2023 · Dec 31, 2022 $43.61M
Short Term Debt Q2 2023 · Jun 30, 2023 $43.92M
Short Term Debt Q2 2023 · Dec 31, 2022 $0
Cash And Equivalents Q2 2023 · Jun 30, 2023 $7.62M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $47.94M
Cash And Equivalents Q2 2023 · Jun 30, 2022 $92.01M
Stockholders Equity Q2 2023 · Jun 30, 2023 −$46.13M
Stockholders Equity Q2 2023 · Mar 31, 2023 −$27.39M
Stockholders Equity Q2 2023 · Dec 31, 2022 −$4.99M
Stockholders Equity Q2 2023 · Jun 30, 2022 $35.65M
Stockholders Equity Q2 2023 · Mar 31, 2022 −$16.8M
Stockholders Equity Q2 2023 · Dec 31, 2021 $8.67M
Current Liabilities Q2 2023 · Jun 30, 2023 $55.54M
Current Liabilities Q2 2023 · Dec 31, 2022 $12.4M
Total Liabilities Q2 2023 · Jun 30, 2023 $66.95M
Total Liabilities Q2 2023 · Dec 31, 2022 $69.43M
Current Assets Q2 2023 · Jun 30, 2023 $11.26M
Current Assets Q2 2023 · Dec 31, 2022 $51.57M
Total Assets Q2 2023 · Jun 30, 2023 $20.82M
Total Assets Q2 2023 · Dec 31, 2022 $64.44M
Eps Diluted Q2 2023 · Jun 30, 2023 −$3.78
Eps Diluted Q2 2023 · Jun 30, 2023 −$8.35
Eps Diluted restated Q2 2023 · Jun 30, 2022 −$8.07
Eps Diluted restated Q2 2023 · Jun 30, 2022 −$18.67
Eps Basic Q2 2023 · Jun 30, 2023 −$3.78
Eps Basic Q2 2023 · Jun 30, 2023 −$8.35
Eps Basic restated Q2 2023 · Jun 30, 2022 −$8.07
Eps Basic restated Q2 2023 · Jun 30, 2022 −$18.67
Sga Expense Q2 2023 · Jun 30, 2023 $4.92M
Sga Expense Q2 2023 · Jun 30, 2023 $11.96M
Sga Expense Q2 2023 · Jun 30, 2022 $8.37M
Sga Expense Q2 2023 · Jun 30, 2022 $17.78M
Rd Expense Q2 2023 · Jun 30, 2023 $13.04M
Rd Expense Q2 2023 · Jun 30, 2023 $30.9M
Rd Expense Q2 2023 · Jun 30, 2022 $21.22M
Rd Expense Q2 2023 · Jun 30, 2022 $40.54M
Net Income Q2 2023 · Jun 30, 2023 −$21.1M
Net Income Q2 2023 · Jun 30, 2023 −$46.44M
Net Income Q2 2023 · Mar 31, 2023 −$25.34M
Net Income Q2 2023 · Jun 30, 2022 −$30.56M
Net Income Q2 2023 · Jun 30, 2022 −$60.42M
Net Income Q2 2023 · Mar 31, 2022 −$29.86M
Operating Income Q2 2023 · Jun 30, 2023 −$19.57M
Operating Income Q2 2023 · Jun 30, 2023 −$44.47M
Operating Income Q2 2023 · Jun 30, 2022 −$29.59M
Operating Income Q2 2023 · Jun 30, 2022 −$58.33M